Search
Search Results
##search.searchResults.foundPlural##
-
EPIDEMIOLOGICAL OVERVIEW OF HODGKIN LYMPHOMA ACROSS THE MEDITERRANEAN BASIN
3567PDF: 1194HTML: 5004Incidence age-standardized rates for HL across the Mediterranean basin: 206 -
THERAPY-RELATED MYELOID NEOPLASM IN NON-HODGKIN LYMPHOMA SURVIVORS
2598PDF: 751HTML: 2307 -
ACUTE LUNG INJURY COMPLICATING BLOOD TRANSFUSION IN POST-PARTUM HEMORRHAGE: INCIDENCE AND RISK FACTORS.
2463PDF: 1240HTML: 3606Acute lung injury complicating blood transfusion in post-partum hemorrhage: incidence and risk factors.: 410 -
TUBERCULOSIS IN TROPICAL AREAS AND IMMIGRANTS
3343PDF: 1323HTML: 6199 -
CMV IN HEMATOPOIETIC STEM CELL TRANSPLANTATION
4827PDF: 1793HTML: 2714Untitled: 222 -
CONCISE REVIEW ON THE FREQUENCY, MAJOR RISK FACTORS AND SURVEILLANCE OF HEPATOCELLULAR CARCINOMA (HCC) IN ?-THALASSEMIAS: PAST, PRESENT AND FUTURE PERSPECTIVES Thalassaemia transfusion dependent, Hepatitis C, hepatocarcinoma.
4287PDF: 1525HTML: 457 -
UPDATE ON CYTOMEGALOVIRUS INFECTION MANAGEMENT IN ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANT RECIPIENTS A Consensus Document of the Spanish Group for Hematopoietic Transplantation and Cell Therapy (GETH-TC)
3969Suppl. Files: 1127PDF: 1083Html: 179 -
CLONAL HEMATOPOIESIS: ROLE IN HEMATOLOGIC NON-HEMATOLOGIC MALIGNANCIES CLONAL HEMATOPOIESIS AND MALIGNANCIES
3028PDF: 910HTML: 1992 -
COMPARISON OF INFECTIOUS COMPLICATIONS IN PATIENTS RECEIVING HIGH-DOSE CYCLOPHOSPHAMIDE AS GVHD AFTER TRANSPLANTATION FROM A 9/10 HLA-MATCHED UNRELATED DONOR WITH STANDARD GVHD PROPHYLAXIS AFTER TRANSPLANT FROM A FULL MATCHING DONOR Infection With PTCy Versus Standard GvHD Prophylaxis
1409PDF: 1321HTML: 101 -
INCIDENCE OF ACUTE MYELOID LEUKEMIA AFTER BREAST CANCER
3289PDF: 943HTML: 2959 -
BACTERIAL INFECTIONS IN HEMATOPOIETIC STEM CELL TRANSPLANT RECIPIENTS
3184PDF: 1839HTML: 3663 -
-
TUBERCULOSIS IN HEMATOPOIETIC STEM CELL TRANSPLANT PATIENTS.
2650PDF: 952HTML: 3643 -
MANAGEMENT OF ACUTE PROMYELOCYTIC LEUKEMIA IN THE ELDERLY
2787PDF: 1129HTML: 3287 -
OCCURRENCE OF SECONDARY MALIGNANCIES IN CHRONIC MYELOID LEUKEMIA DURING THERAPY WITH IMATINIB MESYLATE-SINGLE INSTITUTION EXPERIENCE
2240PDF: 1052HTML: 1989Characteristic of study group: 203 -
VIRAL HEPATITIS A TO E IN SOUTH MEDITERRANEAN COUNTRIES
1258PDF: 650HTML: 7733 -
TUBERCULOSIS: EPIDEMIOLOGY AND CONTROL
7012PDF: 3959HTML: 24890 -
HEMATOPOIETIC CELL TRANSPLANTATION FOR OLDER PATIENTS WITH MDS
2032PDF: 766HTML: 3117 -
ANTIFUNGAL THERAPY IN HEMATOPOIETIC STEM CELL TRANSPLANT RECIPIENTS
4769PDF: 1566HTML: 2251Untitled: 214Untitled: 227Untitled: 234Untitled: 216Untitled: 222 -
HIV-ASSOCIATED VENOUS THROMBOEMBOLISM
3927PDF: 1484HTML: 8515 -
SIMILARITIES OF ELDERLY AND THERAPY-RELATED AML
3628PDF: 895HTML: 6717 -
LOW INCIDENCE RATE OF OPPORTUNISTIC AND VIRAL INFECTIONS DURING IMATINIB TREATMENT IN CHRONIC MYELOID LEUKEMIA PATIENTS IN EARLY AND LATE CHRONIC PHASE
1639PDF: 804HTML: 865jdoe, table 2 infections CML .doc: 197jdoe, table 1 infections CML .doc: 182







